Correlation Between Salarius Pharmaceuticals and Basilea Pharmaceutica
Can any of the company-specific risk be diversified away by investing in both Salarius Pharmaceuticals and Basilea Pharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salarius Pharmaceuticals and Basilea Pharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salarius Pharmaceuticals and Basilea Pharmaceutica AG, you can compare the effects of market volatilities on Salarius Pharmaceuticals and Basilea Pharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salarius Pharmaceuticals with a short position of Basilea Pharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salarius Pharmaceuticals and Basilea Pharmaceutica.
Diversification Opportunities for Salarius Pharmaceuticals and Basilea Pharmaceutica
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Salarius and Basilea is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Salarius Pharmaceuticals and Basilea Pharmaceutica AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Basilea Pharmaceutica and Salarius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salarius Pharmaceuticals are associated (or correlated) with Basilea Pharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Basilea Pharmaceutica has no effect on the direction of Salarius Pharmaceuticals i.e., Salarius Pharmaceuticals and Basilea Pharmaceutica go up and down completely randomly.
Pair Corralation between Salarius Pharmaceuticals and Basilea Pharmaceutica
If you would invest 180.00 in Salarius Pharmaceuticals on November 5, 2024 and sell it today you would earn a total of 35.00 from holding Salarius Pharmaceuticals or generate 19.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Salarius Pharmaceuticals vs. Basilea Pharmaceutica AG
Performance |
Timeline |
Salarius Pharmaceuticals |
Basilea Pharmaceutica |
Salarius Pharmaceuticals and Basilea Pharmaceutica Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Salarius Pharmaceuticals and Basilea Pharmaceutica
The main advantage of trading using opposite Salarius Pharmaceuticals and Basilea Pharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salarius Pharmaceuticals position performs unexpectedly, Basilea Pharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Basilea Pharmaceutica will offset losses from the drop in Basilea Pharmaceutica's long position.Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Histogen | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |